A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Biomarkers of AKI in Patients Receiving Daratumumab
- Status
- COMPLETED
- Phase
- N/A
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
- Status
- COMPLETED
- Phase
- PHASE1
DAratumumab and REvlimid REfractory MM
- Status
- RECRUITING
- Phase
- N/A
Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
- Status
- RECRUITING
- Phase
- N/A
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE3
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Integrative Therapies in Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE3
Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
- Status
- COMPLETED
- Phase
- N/A
Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
- Status
- RECRUITING
- Phase
- NA
A Clinical Study of SHR-9539 in Patients With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1